Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Oligodendroglioma, IDH Mutation and 1p/19q Codeletion].

No shinkei geka. Neurological surgery - 1 Sept 2023

Matsutani Tomoo

Abstract excerpt

Oligodendrogliomas were clearly defined as tumors with IDH mutations and 1p/19q codeletion by the World Health Organization(WHO)in 2016. Their prognosis is better than that of morphologic oligodendrogliomas, which might include some other gliomas according to WHO in 2016 and 2021. The term "low-grade gliomas" does not exist in the WHO classification and has changed in meaning over time; prior to WHO 2016, it...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cognition
Share to Glioma
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oligodendroglioma

Source

Identifiers

PMID: 37743332
DOI: 10.11477/mf.1436204822

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Oligodendroglioma, IDH Mutation and 1p/19q Codeletion].PMID 37743332Read ↗

Oligodendroglioma: pathology, molecular mechanisms and markersSemantic proximity Read ↗

Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomasSemantic proximity Read ↗

Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis.Semantic proximity Read ↗

A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.Semantic proximity Read ↗

The 2007 WHO classification of tumors of the central nervous system – what has changed?Semantic proximity Read ↗

[Evolution of Glioma Diagnosis: The WHO 2021 Classification and Beyond].Semantic proximity Read ↗

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.Semantic proximity Read ↗

[World Health Organization Classification of Central Nervous System Tumours, 5th Edition:Points of the Update and the Current Status].Semantic proximity Read ↗

Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?Semantic proximity Read ↗

Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification.Semantic proximity Read ↗

World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.Semantic proximity Read ↗

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.